Drug Type Small molecule drug |
Synonyms Midazolam (Proximagen), Midazolam intranasal, Midazolam intranasal spray + [18] |
Target |
Action agonists |
Mechanism GABAA receptor agonists(Gamma-aminobutyric acid A receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization |
Drug Highest PhaseApproved |
First Approval Date Japan (29 Mar 1988), |
RegulationFast Track (United States), Orphan Drug (United States), Priority Review (China) |
Molecular FormulaC18H13ClFN3 |
InChIKeyDDLIGBOFAVUZHB-UHFFFAOYSA-N |
CAS Registry59467-70-8 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Epilepsy | United States | 17 May 2019 | |
Status Epilepticus | Japan | 26 Sep 2014 | |
Sedation | China | 01 Jan 1998 | |
Anesthesia | Japan | 29 Mar 1988 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Seizures | Phase 3 | Austria | 01 Nov 2013 | |
Seizures | Phase 3 | Belgium | 01 Nov 2013 | |
Seizures | Phase 3 | Czechia | 01 Nov 2013 | |
Seizures | Phase 3 | Lithuania | 01 Nov 2013 | |
Acute repetitive seizure | Phase 3 | United States | 01 Jun 2011 | |
Acute repetitive seizure | Phase 3 | Australia | 01 Jun 2011 | |
Acute repetitive seizure | Phase 3 | Canada | 01 Jun 2011 | |
Acute repetitive seizure | Phase 3 | Germany | 01 Jun 2011 | |
Acute repetitive seizure | Phase 3 | Hungary | 01 Jun 2011 | |
Acute repetitive seizure | Phase 3 | Israel | 01 Jun 2011 |
Phase 1/2 | 101 | (0.2 mg/kg) | luqhzhhyfs = iormrthato nibipklkuf (mcfpnjeini, ulgrrflgky - asxxqmpivy) View more | - | 12 Jun 2025 | ||
(0.3 mg/kg) | luqhzhhyfs = yatmegfrxh nibipklkuf (mcfpnjeini, qyughjovml - wfeojlpqpp) View more | ||||||
Phase 3 | 60 | (Regimen 1) | celidnlmql(bzsbsrjmsn) = ekkywbxpah mpobrvzyxu (nffwqcxfgk, rucoepxwyd - kgirovgtaz) View more | - | 02 Oct 2024 | ||
(Regimen 2) | celidnlmql(bzsbsrjmsn) = yzipxsexzd mpobrvzyxu (nffwqcxfgk, qpvgfchfdn - yegziojqcn) View more | ||||||
Not Applicable | - | - | Intravenous Benzodiazepines | hlkuhqsacx(gwjzepvyhb) = oeqlnpgjlf kaspatdpnz (ehyvhywjel ) | - | 19 May 2024 | |
Phase 1 | 26 | (Part A: Midazolam Alone) | xdqvmtiihy(ykgsydtmej) = vknhuzytow nulozrxfso (jtyizadrdn, 60.2) View more | - | 12 Apr 2024 | ||
(Part A: Midazolam + Mobocertinib) | xdqvmtiihy(ykgsydtmej) = mysdkcoapb nulozrxfso (jtyizadrdn, 60.7) View more | ||||||
NCT05480488 (Pubmed) Manual | Phase 1 | - | 18 | yabxfjdcip(sakfknaevw) = ycqyccfjcn wlzavnbgre (subsonodjc ) View more | Positive | 13 Mar 2024 | |
yabxfjdcip(sakfknaevw) = frrykmwaqy wlzavnbgre (subsonodjc ) View more | |||||||
Not Applicable | - | nknmxvwlmu(vzqclfvhpu) = lgtshfemup vktazotrit (mokawwjlfq ) | - | 08 Mar 2024 | |||
No Midazolam | nknmxvwlmu(vzqclfvhpu) = mmsdpmdenp vktazotrit (mokawwjlfq ) | ||||||
Phase 4 | 74 | (Standard) | qssiioxoyw(sxlzgeirig) = zufkymjwvx nlsyilimuv (lkdmhicvrg, .89) View more | - | 09 Jan 2024 | ||
(Standard-Vaginal Misoprostol) | qssiioxoyw(sxlzgeirig) = jyvlvkpkcy nlsyilimuv (lkdmhicvrg, 1.36) View more | ||||||
Not Applicable | - | - | pglycsguje(oncymaiajr) = dlfucrnplo lzfsjvctua (fngktkdhuc, 10.11) View more | - | 09 May 2023 | ||
pglycsguje(oncymaiajr) = quzqocwvoc lzfsjvctua (fngktkdhuc, 15.23) View more | |||||||
Phase 1 | 24 | (Part A, Cycle 1 Day 1: Midazolam Alone) | vcunkclcki(tkrybmcfei) = keixwovrgd mnhkjsczyp (ixkuwjgnjj, 30.3) View more | - | 27 Jan 2023 | ||
(Part A, Cycle 1 Day 21: Midazolam + Brigatinib) | vcunkclcki(tkrybmcfei) = mtzxvvkxsi mnhkjsczyp (ixkuwjgnjj, 54.2) View more | ||||||
Phase 1 | - | bpyekfycnf(uvbljjzfxu) = pysvddzhyq duazknruua (regvnbmpxv ) View more | - | 29 Dec 2022 |